Metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated alcohol-related liver disease in human immunodeficiency virus

doi:10.5501/wjv.v15.i2.120027

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 2

This Article

(20)

(30)

(0)

(19)

(396)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Virology

ISSN

2220-3249

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Virol. Jun 25, 2026; 15(2): 120027
Published online Jun 25, 2026. doi: 10.5501/wjv.v15.i2.120027

Full Size Figure Download Figure

Figure 3 Human immunodeficiency virus-related mechanisms and their roles in metabolic dysfunction-associated steatotic liver disease/metabolic dysfunction-associated alcohol-related liver disease. The images were created using BioRender (Supplementary material). HIV: Human immunodeficiency virus; NRTI: Nucleoside reverse-transcriptase inhibitor; INSTI: Integrase strand transfer inhibitor; LPS: Lipopolysaccharide; PAMP: Pathogen-associated molecular pattern; MASLD: Metabolic dysfunction-associated steatotic liver disease; MetALD: Metabolic dysfunction-associated alcohol-related liver disease; TLR4: Toll-like receptor 4; IL: Interleukin; PLHW: People living with human immunodeficiency virus; ROS: Reactive oxygen species; CYP2E1: Cytochrome P450 2E1.

Citation: Bandara D, Joshi K, Singh C, Sohal A, Al-Qaisi M, Najafian N. Metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated alcohol-related liver disease in human immunodeficiency virus. World J Virol 2026; 15(2): 120027
URL: https://www.wjgnet.com/2220-3249/full/v15/i2/120027.htm
DOI: https://dx.doi.org/10.5501/wjv.v15.i2.120027

Bandara D, Joshi K, Singh C, Sohal A, Al-Qaisi M, Najafian N. Metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated alcohol-related liver disease in human immunodeficiency virus. World J Virol 2026; 15(2): 120027 [PMID: 42395037 DOI: 10.5501/wjv.v15.i2.120027]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.